Epidermal growth factor receptor/c-erbB-2 heterodimers are constitutively formed on breast cancer cells, thereby determining a motogenic phenotype (Brandt et al, 1999) through the above-mentioned mechanism (Dittmar et al, 2002). The gene discussed is EGFR; the disease is breast cancer.